Industry

FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction to acquire MiroBio, a privately held U.K.-based biotechnology company focused on restoring immune balance with agonists targeting immune inhibitory receptors, for approximately $405 million in cash. The acquisition provides Gilead with MiroBio’s proprietary discovery platform and entire portfolio … [Read more…]

Advanced Services Business Model Driving Growth Opportunities and Recurring, High Visibility Revenue Well Positioned in Large and Growing Market Segments SANTA CLARA, Calif.–(BUSINESS WIRE)–Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leading provider of medication management and adherence tools for health systems and pharmacies, held its 2022 Investor Day today and provided an in-depth … [Read more…]

Andy Grammer, Kiiara, and More Join in Celebration of World Mental Health Day on October 10. LOS ANGELES–(BUSINESS WIRE)–Today marks the announcement of 320 ExperiMENTAL, a mental health awareness event and benefit concert co-produced by USC students in a class of Warped Tour founder Kevin Lyman, Talinda Bennington, widow of the late Chester Bennington of … [Read more…]

Annual State of the TMC showcases emerging campuses at Texas Medical Center HOUSTON–(BUSINESS WIRE)–William (Bill) McKeon, President and CEO of Texas Medical Center, today shared plans for the continued strategic growth of the Texas Medical Center at the annual State of the TMC, hosted by the Greater Houston Partnership. With a vision to become the … [Read more…]

Dialysis-like Cell Removal Therapy to be Studied for Treating Metastatic Cancer MARTINEZ, Calif.–(BUSINESS WIRE)–ExThera Medical is pleased to announce that published data from a preliminary European study demonstrating in vitro adsorption of human circulating tumor cells (CTC) has been corroborated at a major US cancer center. CTCs are responsible for the often-fatal spread or metastasis … [Read more…]

The free-standing 96-bed facility will help meet the region’s rapidly growing need for mental health services BRENTWOOD, Tenn. & PHOENIX–(BUSINESS WIRE)–Kindred Behavioral Health (KBH), a business unit of LifePoint Health, and Dignity Health today announced the signing of a letter of intent to build and operate a new inpatient behavioral health hospital on the campus … [Read more…]

Seramount (formerly Working Mother Media) recognized Zoetis for forward-thinking programs and benefits related to parental leave, family support, wellness offerings and job flexibility A.J. Edge and Daniel Edge, DVM, Named Zoetis’ Working Parents of the Year PARSIPPANY, N.J.–(BUSINESS WIRE)–$ZTS #LifeatZoetis–For the ninth year in a row, Zoetis has been named one of Seramount’s 100 Best … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Lab Automation in Genomics Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027)” report has been added to ResearchAndMarkets.com’s offering. The Global Lab Automation in the Genomics market is expected to grow at a CAGR of 7.70% over the forecast period (2021-2026). With the technological advancements and increasing computational capacities, there … [Read more…]

Klick Health adds George Yancopoulos, Tal Zaks, and Rick Bright to speaker line-up at inspirational September 22nd life sciences industry event NEW YORK–(BUSINESS WIRE)–Klick Health today announced that Regeneron Co-Founder George Yancopoulos, former Moderna Chief Medical Officer Tal Zaks, and former Deputy Assistant Secretary for Preparedness and Response/Director of the Biomedical Advanced Research and Development … [Read more…]

MADISON, Wis.–(BUSINESS WIRE)–Invenra, a company developing next generation therapeutic antibodies, announced today that Chief Scientific Officer Daniel Pereira, Ph.D., will present preclinical data supporting the ongoing development of INV322, an antibody-based cancer therapeutic. The preclinical research findings will be presented at the 13th Annual World Bispecific Summit, Thursday, September 22nd, 2022 and at the Immuno-Oncology … [Read more…]